Table 4.
Plasma biomarker | Importance in ALI/ARDS development | Associated outcomes other than ALI/ARDS |
---|---|---|
Surfactant protein-D44–46 | Reflect injury and ↑ permeability of alveolar epithelium | VFD, organ failure |
Receptor for advanced glycation end products47–49 | Reflects endothelial activation and injury | VFD,49 organ failure,49 ARDS after lung transplant47 |
Intercellular adhesion molecule-144 50–53 | Reflects endothelial activation and injury | VFD,51 organ failure51 |
Interleukin-644 54–56 | Inflammation | VFD,55 organ failure55 |
Interleukin-844 48 50 54–56 | Inflammation | VFD,55organ failure55 |
Plasminogen activator inhibitor-144 50 57–61 | Activation of coagulation and inhibition of fibrinolysis | VFD,61 organ failure61 |
von Willebrand factor44 48 60 62 63 | Reflects endothelial activation and injury | Organ failure |
Protein C44 50 59 61–64 | Activation of coagulation and inhibition of fibrinolysis | ARDS after lung transplant,47 VFD,61 organ failure61 |
ALI, acute lung injury; ARDS, acute respiratory distress syndrome; VFD, ventilator-free days.